Cipla Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:Cipla Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4849
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Cipla Limited – Strategy, SWOT and Corporate Finance Report
Summary

Cipla Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cipla Limited (Cipla or ‘the company’) is a manufacturer of prescription drugs, veterinary and active pharmaceutical ingredient products. The company provides products for various therapeutic categories including dermatology, critical care, cardiovascular, infectious diseases, children’s health, and cosmetology, HIV/AIDS, diabetes, neurosciences, hepatitis, malaria, oncology, ophthalmology, respiratory, osteoporosis and urology. The company is also engaged in biosimilar and consumer healthcare. Cipla operates state-of-the-art research facilities for API process development in India and has dedicated cancer and polypeptide development laboratories. The company offers its products in South Africa, India, and North America and other markets. Cipla is headquartered in Mumbai, Maharashtra, India.

Scope

- Detailed information on Cipla Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cipla Limited in the form of a SWOT analysis
- An in-depth view of the business model of Cipla Limited including a breakdown and examination of key business segments
- Intelligence on Cipla Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cipla Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cipla Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cipla Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cipla Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Cipla Limited: Company Overview
Cipla Limited: Overview and Key Facts
Cipla Limited: Overview
Cipla Limited: Key Facts
Cipla Limited: Key Employees
Cipla Limited: Key Employee Biographies
Cipla Limited: Major Products and Services
Cipla Limited: Company History
Cipla Limited: Management Statement
Cipla Limited: Locations and Subsidiaries
Cipla Limited: Key Competitors
Cipla Limited: Company Analysis
Cipla Limited: Business Description
Cipla Limited: SWOT Analysis
Cipla Limited: SWOT Overview
Cipla Limited: Strengths
Cipla Limited: Weaknesses
Cipla Limited: Opportunities
Cipla Limited: Threats
Cipla Limited: Corporate Financial Deals Activity
Cipla Limited: Financial Deals Overview
Cipla Limited: Targets and Partners
Cipla Limited: Top Deals 2016 – 2020YTD*
Cipla Limited: Mergers and Acquisitions
Cipla Limited: Capital Raising
Cipla Limited: Partnership
Cipla Limited: Divestments
Cipla Limited: Recent Developments
Cipla Limited: News and Events Summary
Cipla Limited: Contracts
Cipla Limited: Corporate Governance
Cipla Limited: Financial Deals
Cipla Limited: Financial Performance
Cipla Limited: Market Developments
Cipla Limited: Regulatory and Legal Events
Cipla Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Cipla Limited: Key Facts
Table 2: Cipla Limited: Key Employees
Table 3: Cipla Limited: Company History
Table 4: Cipla Limited: Locations and Subsidiaries
Table 5: Cipla Limited: Key Competitors
Table 6: Cipla Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Cipla Limited: M&A Activity by Geography (TTM*)
Table 8: Cipla Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Cipla Limited: M&A Average Deal Size - Value (US$m)
Table 10: Cipla Limited: Targets and Partners
Table 11: Cipla Limited: Top Deals 2016 - 2020YTD*
Table 12: Cipla Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Cipla Limited: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Cipla Limited: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Cipla Limited: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Cipla Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Cipla Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Cipla Limited: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Cipla Limited: Divestments by Geography (2016 - YTD*2020)
Table 20: Cipla Limited: News and Events Summary
Table 21: Cipla Limited: Contracts
Table 22: Cipla Limited: Corporate Governance
Table 23: Cipla Limited: Financial Deals
Table 24: Cipla Limited: Financial Performance
Table 25: Cipla Limited: Market Developments
Table 26: Cipla Limited: Regulatory and Legal Events
Table 27: Cipla Limited: Strategy and Operations

★海外企業調査レポート[Cipla Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shockwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of advanced cardiovascular diseases. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology which built on balloon catheter platform for the tr …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PT ANTAM (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ARxIUM-医療機器分野:企業M&A・提携分析
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • JAFCO Co., Ltd.:企業のM&A・事業提携・投資動向
    JAFCO Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JAFCO Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • MeiraGTx Holdings Plc (MGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary MeiraGTx Holdings Plc (MeiraGTx) is an independent clinical-stage gene therapy company that focuses on the development of therapeutics for the treatment of eye, salivary gland and neurodegenerative diseases. The company’s pipeline of preclinical and research programs include AAV-CNGB3, for a …
  • BioDot Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioDot Inc (BioDot) is a non-contact and quantitative fluid dispensing system manufacturer. The company’s application comprises rapid test, cytogenetics and life science. It provides lateral flow, immunoblots, dry chemistry, low volume PCR, bio chips, biosensors, fish, karyotyping and LIS in …
  • MediaValet Inc.:戦略・SWOT・企業財務分析
    MediaValet Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaValet Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • PanAtlantic Exploration Co:企業の戦略的SWOT分析
    PanAtlantic Exploration Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • New Zealand Oil & Gas Ltd (NZO):石油・ガス:M&Aディール及び事業提携情報
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • aap Implantate AG (AAQ):企業の財務・戦略的SWOT分析
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Saudi Cable Company (2110):企業の財務・戦略的SWOT分析
    Saudi Cable Company (2110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Crown Resorts Ltd:企業の戦略・SWOT・財務分析
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • Corus Entertainment Inc. (CJR.B):企業の財務・戦略的SWOT分析
    Corus Entertainment Inc. (CJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ipsos SA (IPS):企業の財務・戦略的SWOT分析
    Ipsos SA (IPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Bajaj Allianz Life Insurance Company Ltd:企業の戦略・SWOT・財務情報
    Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • QRxPharma Ltd:企業の戦略的SWOT分析
    QRxPharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆